Compile Data Set for Download or QSAR
maximum 50k data
Found 22 of ph data with Target = 'Prostacyclin receptor'
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23960(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6g | 5-{[...)
Affinity DataIC50:  53nM EC50:  51nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23953(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6a | 5-{[...)
Affinity DataIC50:  77nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23959(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6f | 5-{[...)
Affinity DataIC50:  331nM EC50:  358nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23963((2S)-2-[(5-{[4-(3-acetamidophenyl)phenyl]methyl}-1...)
Affinity DataIC50:  476nM EC50:  16nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23955(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6b | N-be...)
Affinity DataIC50:  561nM EC50:  66nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23956(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6c | 5-{[...)
Affinity DataIC50:  721nM EC50:  138nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23961(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6h | 5-{[...)
Affinity DataIC50:  916nM EC50:  296nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23957(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6d | 5-{[...)
Affinity DataIC50:  1.23E+3nM EC50:  278nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23967(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6n | 5-{[...)
Affinity DataIC50:  3.48E+3nM EC50:  828nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23962((2R)-2-[(5-{[4-(3-acetamidophenyl)phenyl]methyl}-1...)
Affinity DataIC50:  4.20E+3nM EC50:  831nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23966(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6m | 5-{[...)
Affinity DataIC50:  4.71E+3nM EC50:  476nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23965(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6l | 5-{[...)
Affinity DataIC50:  4.95E+3nM EC50:  741nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23958(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6e | 5-{[...)
Affinity DataIC50:  7.16E+3nM EC50:  2.13E+3nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23964(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6k | 5-{[...)
Affinity DataIC50:  7.60E+3nM EC50:  1.01E+3nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23968(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6o | 5-{[...)
Affinity DataIC50:  1.22E+4nM EC50:  3.31E+3nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23969(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6p | 5-{[...)
Affinity DataIC50:  1.24E+4nM EC50:  3.58E+3nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM23970(5-(4-phenylbenzyl)oxazole-4-carboxamide, 6q | N-[2...)
Affinity DataIC50:  3.41E+4nM EC50:  3.31E+3nMpH: 7.4 T: 2°CAssay Description:IP receptor binding activity was quantified via a filter binding assay measuring displacement of [3H]-Iloprost binding to human platelet membranes. R...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM62356(US9422273, 12b)
Affinity DataEC50:  860nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM240744(US9422273, 12a)
Affinity DataEC50:  550nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM240745(US9422273, 12c)
Affinity DataEC50:  9.50E+3nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM240746(US9422273, 12d)
Affinity DataEC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstacyclin receptor(Homo sapiens (Human))
Pharmacopeia Drug Discovery

LigandPNGBDBM240747(US9422273, 12e)
Affinity DataEC50:  290nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent